ALGS vs ED · rev $3.6M vs P/E 18, rev $15.26B
Aligos Therapeutics Inc (ALGS) versus Consolidated Edison Inc (ED) — a side-by-side from cached financials, not a winner call.
Aligos Therapeutics Inc (ALGS) is a biotechnology company listed on US.
Consolidated Edison Inc (ED) is a utilities - regulated electric company listed on US.
Latest reported ALGS revenue for 2024-12-31 was $3.6M. Net income was -$131.2M. Revenue was down 41.7% from 2023-12-31 to 2024-12-31. ALGS currently screens at market cap $44.1M.
Latest reported ED revenue for 2024-12-31 was $15.26B. Net income was $1.82B. Revenue was up 4.0% from 2023-12-31 to 2024-12-31. ED currently screens at market cap $36.02B and trailing P/E 18.3.
ALGS currently screens at market cap $44.1M. ED currently screens at market cap $36.02B and trailing P/E 18.3.
Not investment advice. Open the ALGS and ED stock pages for the full models.
Not investment advice.